Comprehensive Community Action, Inc.: drugs
Schedule G of this filing lists 19 drugs, with an amount and a number of claims for each, as filed. Every amount links to its page of the filing.
The schedule's total is printed as “Total Costs of Prescription Drugs Obtained Through 340B Program Claimed for Reimbursement”. The filings describe the amounts in more than one way. Methods says more.
- 19drugs listed
- $250,279.19 (Schedule G, printed total, page 9 of the filing PDF)Total as filed
- 4,960 (Schedule G, printed claims total, page 9 of the filing PDF)Claims total as filed
- 2rows show “fewer than 6” for claims. What this means
All 19 drug rows
| Line | Drug | Amount as filed | Claims as filed |
|---|---|---|---|
| 1 | Trulicity 3 mg/0.5 mL Inj00002223680Listed by the FDA as Trulicitydulaglutide3 mg/0.5 mLinjection, solutionEli Lilly and Company | 14,542.08 (Schedule G, line 1, page 8 of the filing PDF) | 37 |
| 2 | Trulicity 0.75 mg/0.5 mL Inj00002143380Listed by the FDA as Trulicitydulaglutide0.75 mg/0.5 mLinjection, solutionEli Lilly and Company | 14,542.08 (Schedule G, line 2, page 8 of the filing PDF) | 49 |
| 3 | Mounjaro 5 mg/0.5 mL Inj00002149580Listed by the FDA as Mounjarotirzepatide5 mg/0.5 mLinjection, solutionEli Lilly and Company | 12,512.25 (Schedule G, line 3, page 8 of the filing PDF) | 20 |
| 4 | Mounjaro 7.5 mg/0.5 mL Inj00002148480Listed by the FDA as Mounjarotirzepatide7.5 mg/0.5 mLinjection, solutionEli Lilly and Company | 11,678.10 (Schedule G, line 4, page 8 of the filing PDF) | 25 |
| 5 | Trulicity 1.5 mg/0.5 mL Inj00002143480Listed by the FDA as Trulicitydulaglutide1.5 mg/0.5 mLinjection, solutionEli Lilly and Company | 11,360.75 (Schedule G, line 5, page 8 of the filing PDF) | 36 |
| 6 | Januvia 50 mg/0.5 mL Inj00006011231Listed by the FDA as Januviasitagliptin50 mgtablet, film coatedMerck Sharp & Dohme LLC | 11,307.19 (Schedule G, line 6, page 8 of the filing PDF) | 61 |
| 7 | Ozempic 2 mg00169477212Listed by the FDA as Ozempicsemaglutide2.68 mg/mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP | 11,018.74 (Schedule G, line 7, page 8 of the filing PDF) | 65 |
| 8 | Trelegy Ellipta 100-62.5 mcg00173089310Listed by the FDA as Trelegy Elliptafluticasone furoate, umeclidinium bromide and vilanterol trifenatate200 mcg; 62.5 mcg; 25 mcgpowderGlaxoSmithKline LLC | 10,988.01 (Schedule G, line 8, page 8 of the filing PDF) | 118 |
| 9 | Mounjaro 2.5 mg/0.5 mL Inj00002150680Listed by the FDA as Mounjarotirzepatide2.5 mg/0.5 mLinjection, solutionEli Lilly and Company | 10,844.08 (Schedule G, line 9, page 8 of the filing PDF) | 19 |
| 10 | Ozempic 0.25 OR 0.5 mg00169418113Listed by the FDA as Ozempicsemaglutide0.68 mg/mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP | 10,149.51 (Schedule G, line 10, page 8 of the filing PDF) | 41 |
| 11 | Januvia 100 mg Tablets00006027731Listed by the FDA as Januviasitagliptin100 mgtablet, film coatedMerck Sharp & Dohme LLC | 7,937.52 (Schedule G, line 11, page 8 of the filing PDF) | 39 |
| 12 | Ozempic 1 mg00169413013Listed by the FDA as Ozempicsemaglutide1.34 mg/mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP | 7,000.40 (Schedule G, line 12, page 8 of the filing PDF) | 46 |
| 13 | Januvia 25 mg Tablets00006022131Listed by the FDA as Januviasitagliptin25 mgtablet, film coatedMerck Sharp & Dohme LLC | 6,613.34 (Schedule G, line 13, page 8 of the filing PDF) | 38 |
| 14 | Wegovy 2.4 mg/0.75 mL00169452414Listed by the FDA as Wegovysemaglutide2.4 mg/0.75 mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP | 5,618.88 (Schedule G, line 14, page 8 of the filing PDF) | 15 |
| 15 | Trulicity 4.5 mg/0.5 mL Inj00002318280Listed by the FDA as Trulicitydulaglutide4.5 mg/0.5 mLinjection, solutionEli Lilly and Company | 5,471.06 (Schedule G, line 15, page 8 of the filing PDF) | 9 |
| 16 | Zepbound 5 mg/0.5 mL Inj00002250680Listed by the FDA as Zepboundtirzepatide2.5 mg/0.5 mLinjection, solutionEli Lilly and Company | 5,216.10 (Schedule G, line 16, page 8 of the filing PDF) | 14 |
| 17 | Genvoya Tab61958190101Listed by the FDA as Genvoyaelvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide150 mg; 150 mg; 200 mg; 10 mgtabletGilead Sciences, Inc. | 5,168.92 (Schedule G, line 17, page 8 of the filing PDF) | fewer than 6 (the count is not shown) |
| 18 | Rexulti 2 mg Tablets59148003813Listed by the FDA as Rexultibrexpiprazole2 mgtabletOtsuka America Pharmaceutical, Inc. | 5,005.34 (Schedule G, line 18, page 8 of the filing PDF) | fewer than 6 (the count is not shown) |
| 19 | Mounjaro 12.5 mg/0.5 mL Inj00002146080Listed by the FDA as Mounjarotirzepatide12.5 mg/0.5 mLinjection, solutionEli Lilly and Company | 5,004.90 (Schedule G, line 19, page 8 of the filing PDF) | 10 |
No row matches. | |||
| Total Prescription Drugs individually under $5,000 | 78,299.94 (Schedule G, row for amounts under $5,000, page 9 of the filing PDF) | 4,309 (Schedule G, claims on the row for amounts under $5,000, page 9 of the filing PDF) | |
| Total Costs of Prescription Drugs Obtained Through 340B Program Claimed for Reimbursement | 250,279.19 (Schedule G, printed total, page 9 of the filing PDF) | 4,960 (Schedule G, printed claims total, page 9 of the filing PDF) | |
The rows at the foot of the table are always shown. The sum above does not include them.
What “fewer than 6” means. A count of 1 to 5 is not shown on this site or in its data files. Methods, section 9, says how.
Amounts and counts are the filer’s own, in US dollars. They are written here with commas between thousands, and an amount filed with one decimal place is written with two. No value is changed: the filing and the download keep each figure as typed.
Drug names are the filer’s own words. Filers type them in many ways, so this page writes them one way: capitals, spaces, unit names such as mg and mL, a zero before a decimal point, and commas in long numbers. No word is changed, spelled out or left out, and shorthand stays as the filer typed it. The filing and the download keep each name as typed, and a search here reads both.
“Listed by the FDA as” is not part of the filing. It is the name, ingredient, strength, form and labeler that the U.S. Food and Drug Administration’s National Drug Code Directory lists for the row’s code, as downloaded on 11 November 2026. All 19 rows have one. A row has none when its code is not filed as one 11-digit code or the directory has never listed it. Where the directory has since dropped a code, the name is kept as it was last listed, and the line says so. The directory’s capitals, strengths and unit names are written one way on this page. How a code is matched
Source
- Filing PDF
- Open Schedule G on the State of Rhode Island's website
- SHA-256
- 2528914b3ef2fd63001405cb7b31e54b950a59d5ee7789b88f4bac9497245ce1
- Retrieved
- 11 November 2026
- Pages used
- 8 to 9 of 11